A Flagship VentureLabs Company

Syros Pharmaceuticals

480 Arsenal Street, Suite 130

Watertown, MA  02472

Tel: 617.744.1340


Leadership:
Nancy Simonian, M.D.
CEO


Website:
www.syros.com


Information:
info@syros.com

Syros Pharmaceuticals

Flagship Partners:  Doug Cole, Noubar Afeyan
Initial Investment: 
2012
Status: 
Private

Syros Pharmaceuticals is a therapeutics company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros’ proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics. Syros’ initial focus is in cancer, but the company platform will also be applicable to other therapeutic areas.

Doug Cole is on the Board of Directors.